372 related articles for article (PubMed ID: 21890736)
21. Dioxin-elicited decrease in cobalamin redirects propionyl-CoA metabolism to the β-oxidation-like pathway resulting in acrylyl-CoA conjugate buildup.
Orlowska K; Fling RR; Nault R; Sink WJ; Schilmiller AL; Zacharewski T
J Biol Chem; 2022 Sep; 298(9):102301. PubMed ID: 35931118
[TBL] [Abstract][Full Text] [Related]
22. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y
J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440
[TBL] [Abstract][Full Text] [Related]
23. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
[TBL] [Abstract][Full Text] [Related]
24. Sirt1 counteracts decrease in membrane phospholipid unsaturation and diastolic dysfunction during saturated fatty acid overload.
Yamamoto T; Endo J; Kataoka M; Matsuhashi T; Katsumata Y; Shirakawa K; Yoshida N; Isobe S; Moriyama H; Goto S; Yamashita K; Ohto-Nakanishi T; Nakanishi H; Shimanaka Y; Kono N; Shinmura K; Arai H; Fukuda K; Sano M
J Mol Cell Cardiol; 2019 Aug; 133():1-11. PubMed ID: 31145942
[TBL] [Abstract][Full Text] [Related]
25. 2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion.
Bui P; Solaimani P; Wu X; Hankinson O
Toxicol Appl Pharmacol; 2012 Mar; 259(2):143-51. PubMed ID: 22230337
[TBL] [Abstract][Full Text] [Related]
26. Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver.
Sato S; Shirakawa H; Tomita S; Ohsaki Y; Haketa K; Tooi O; Santo N; Tohkin M; Furukawa Y; Gonzalez FJ; Komai M
Toxicol Appl Pharmacol; 2008 May; 229(1):10-9. PubMed ID: 18295293
[TBL] [Abstract][Full Text] [Related]
27. Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin.
Pierre S; Chevallier A; Teixeira-Clerc F; Ambolet-Camoit A; Bui LC; Bats AS; Fournet JC; Fernandez-Salguero P; Aggerbeck M; Lotersztajn S; Barouki R; Coumoul X
Toxicol Sci; 2014 Jan; 137(1):114-24. PubMed ID: 24154488
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profile by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the liver of wild-type (AhR+/+) and aryl hydrocarbon receptor-deficient (AhR-/-) mice.
Yoon CY; Park M; Kim BH; Park JY; Park MS; Jeong YK; Kwon H; Jung HK; Kang H; Lee YS; Lee BJ
J Vet Med Sci; 2006 Jul; 68(7):663-8. PubMed ID: 16891777
[TBL] [Abstract][Full Text] [Related]
29. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation.
Chu K; Miyazaki M; Man WC; Ntambi JM
Mol Cell Biol; 2006 Sep; 26(18):6786-98. PubMed ID: 16943421
[TBL] [Abstract][Full Text] [Related]
30. Chronic exposure of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces an obesogenic effect in C57BL/6J mice fed a high fat diet.
Brulport A; Le Corre L; Chagnon MC
Toxicology; 2017 Sep; 390():43-52. PubMed ID: 28774668
[TBL] [Abstract][Full Text] [Related]
31. Differences in acute toxicity syndromes of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin in rats.
Niittynen M; Simanainen U; Syrjälä P; Pohjanvirta R; Viluksela M; Tuomisto J; Tuomisto JT
Toxicology; 2007 Jun; 235(1-2):39-51. PubMed ID: 17448584
[TBL] [Abstract][Full Text] [Related]
32. Omega-3 fatty acid deficiency augments risperidone-induced hepatic steatosis in rats: positive association with stearoyl-CoA desaturase.
McNamara RK; Magrisso IJ; Hofacer R; Jandacek R; Rider T; Tso P; Benoit SC
Pharmacol Res; 2012 Oct; 66(4):283-91. PubMed ID: 22750665
[TBL] [Abstract][Full Text] [Related]
33. Hepatocyte-Specific Deletion of TIPARP, a Negative Regulator of the Aryl Hydrocarbon Receptor, Is Sufficient to Increase Sensitivity to Dioxin-Induced Wasting Syndrome.
Hutin D; Tamblyn L; Gomez A; Grimaldi G; Soedling H; Cho T; Ahmed S; Lucas C; Kanduri C; Grant DM; Matthews J
Toxicol Sci; 2018 Oct; 165(2):347-360. PubMed ID: 29873790
[TBL] [Abstract][Full Text] [Related]
34. Characterizing the Role of HMG-CoA Reductase in Aryl Hydrocarbon Receptor-Mediated Liver Injury in C57BL/6 Mice.
Dornbos P; Jurgelewicz A; Fader KA; Williams K; Zacharewski TR; LaPres JJ
Sci Rep; 2019 Nov; 9(1):15828. PubMed ID: 31676775
[TBL] [Abstract][Full Text] [Related]
35. Dietary cholesterol opposes PUFA-mediated repression of the stearoyl-CoA desaturase-1 gene by SREBP-1 independent mechanism.
Kim HJ; Miyazaki M; Ntambi JM
J Lipid Res; 2002 Oct; 43(10):1750-7. PubMed ID: 12364560
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Hepatic NRF2 and Aryl Hydrocarbon Receptor Binding in 2,3,7,8-Tetrachlorodibenzo-
Nault R; Doskey CM; Fader KA; Rockwell CE; Zacharewski T
Mol Pharmacol; 2018 Aug; 94(2):876-884. PubMed ID: 29752288
[TBL] [Abstract][Full Text] [Related]
37. BTG1 ameliorates liver steatosis by decreasing stearoyl-CoA desaturase 1 (SCD1) abundance and altering hepatic lipid metabolism.
Xiao F; Deng J; Guo Y; Niu Y; Yuan F; Yu J; Chen S; Guo F
Sci Signal; 2016 May; 9(428):ra50. PubMed ID: 27188441
[TBL] [Abstract][Full Text] [Related]
38. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces plasminogen activator inhibitor-1 through an aryl hydrocarbon receptor-mediated pathway in mouse hepatoma cell lines.
Son DS; Rozman KK
Arch Toxicol; 2002 Jul; 76(7):404-13. PubMed ID: 12111005
[TBL] [Abstract][Full Text] [Related]
39. Aryl hydrocarbon receptor expression and activity in cerebellar granule neuroblasts: implications for development and dioxin neurotoxicity.
Williamson MA; Gasiewicz TA; Opanashuk LA
Toxicol Sci; 2005 Feb; 83(2):340-8. PubMed ID: 15537747
[TBL] [Abstract][Full Text] [Related]
40. Omega-3 fatty acid deficiency increases stearoyl-CoA desaturase expression and activity indices in rat liver: positive association with non-fasting plasma triglyceride levels.
Hofacer R; Magrisso IJ; Jandacek R; Rider T; Tso P; Benoit SC; McNamara RK
Prostaglandins Leukot Essent Fatty Acids; 2012; 86(1-2):71-7. PubMed ID: 22047910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
